MyFinsight
Home
Blog
About
Contact
Download
Download image
Marketable securities
(note 5)
$349,723K
Cash and cash
equivalents
$199,163K
Prepaid expenses and
other current assets
$10,392K
Other receivables
$1,371K
Total current assets
$560,649K
Marketable securities,
long-term (note 5)
$37,152K
Deferred tax assets (note
14)
$12,864K
Property, plant and
equipment, net (note 6)
$8,721K
Prepaid expenses,
long-term
$7,151K
Operating lease
right-of-use asset, net (note...
$6,626K
Total assets
$633,163K
Total liabilities and
shareholders equity
$633,163K
Total shareholders'
equity
$581,760K
Total liabilities
$51,403K
Accumulated deficit
-$1,245,380K
Common shares, without
par value unlimited...
$1,598,571K
Total current
liabilities
$41,792K
Operating lease
liability, long-term (note...
$6,412K
Other liabilities,
long-term
$3,199K
Additional paid-in capital
$228,234K
Accumulated other
comprehensive income (loss)
$335K
Accounts payable and
accrued liabilities...
$40,260K
Operating lease liability
(note 7)
$1,532K
Back
Back
Balance Sheet
source: myfinsight.com
logo_icon_teal_2280px-svg
Xenon Pharmaceuticals Inc. (XENE)
logo_icon_teal_2280px-svg
Xenon Pharmaceuticals Inc. (XENE)